ISPC logo

ISPC iSpecimen Inc.

NASDAQ Capital Market · Medical - Diagnostics & Research · Healthcare

$1.05
-0.03 (-2.78%)

iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a …

Market Cap: $2.64Mispecimen.com

Price

$2.22-12.60%
$1.83$2.07$2.30$2.54
Jul 9Aug 7

Social Signal Score

41
5d
—
30d
50
1 mentions
+0.0%
60d
37
3 mentions
+0.0%
90d
37
3 mentions
-3.1%
news: 3

Analyst Ratings

2 analysts
Buyconsensus
Strong Buy 0Buy 2Hold 0Sell 0Strong Sell 0

Revenue

$151.9K-78.07%
$51.8K$1.02M$1.99M$2.96M
Sep 2019Jun 2026

Analyst Estimates

FY2025
$-632.00
$-632.00–$-632.00
1 analysts
FY2026
$0.00
$0.00–$0.00
0 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Shahin Behroyan
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
7
Beta
1.62
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-21.19
ispecimen.com